Format

Send to

Choose Destination
Curr Respir Care Rep. 2012 Sep;1(3):157-161.

Antibody-Mediated Lung Transplant Rejection.

Author information

1
Washington University School of Medicine, Division of Pulmonary & Critical Care Medicine, 660 S. Euclid Ave., Campus Box 8052, St. Louis, MO 63110, USA, Rhachem@dom.wustl.edu.

Abstract

Antibody-mediated rejection after lung transplantation remains enigmatic. However, emerging evidence over the past several years suggests that humoral immunity plays an important role in allograft rejection. Indeed, the development of donor-specific antibodies after transplantation has been identified as an independent risk factor for acute cellular rejection and bronchiolitis obliterans syndrome. Furthermore, cases of acute antibody-mediated rejection resulting in severe allograft dysfunction have been reported, and these demonstrate that antibodies can directly injure the allograft. However, the incidence and toll of antibody-mediated rejection are unknown because there is no widely accepted definition and some cases may be unrecognized. Clearly, humoral immunity has become an important area for research and clinical investigation.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center